Treatment response to sunitinib in imatinib-resistant recurrence of dermatofibrosarcoma protuberans on the capillitium

被引：0
|
作者：
Mueller, C. [1 ]
Scheib, C. [1 ]
Peller, V. [1 ]
Zillikens, H. [1 ]
Rudolph, V. [1 ]
Leven, A. S. [1 ]
Bauer, S. [2 ]
Pretzell, I. [3 ]
Griewank, K. [1 ]
Sucker, A. [1 ]
Hadaschik, E. [1 ]
Roesch, A. [1 ,2 ]
Ugurel, S. [1 ]
Schadendorf, D. [1 ,2 ]
Zimmer, L. [1 ]
Livingstone, E. [1 ]
机构：
[1] Univ Klinikum Essen, Dermatol, Essen, Germany
[2] Deutsches Konsortium Translat Krebsforsch DKTK, Essen, Germany
[3] Univ Klinikum Essen, Westdeutsches Tumorzentrum, Essen, Germany
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2023年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
eP119
引用
收藏
页码：99 / 100
页数：2
相关论文
共 50 条
  • [41] Successful treatment of imatinib-resistant hypereosinophilic syndrome with nilotinib
    Ikezoe, Takayuki
    Togitani, Kazuto
    Tasaka, Taizo
    Nishioka, Chie
    Yokoyama, Akihito
    LEUKEMIA RESEARCH, 2010, 34 (08) : E200 - E201
  • [42] Sunitinib (SU) response in imatinib-resistant (IM-R) GIST correlates with KIT and PDGFRA mutation status.
    Heinrich, M. C.
    Maki, R. G.
    Corless, C. L.
    Antonescu, C. R.
    Fletcher, J. A.
    Fletcher, C. D.
    Huang, X.
    Baum, C. M.
    Demetri, G. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 520S - 520S
  • [43] Dermatofibrosarcoma protuberans – the use of neoadjuvant imatinib for treatment of an uncommon breast malignancy: a case report
    Matthew W. McGee
    Sarag A. Boukhar
    Varun Monga
    Ronald Weigel
    Sneha D. Phadke
    Journal of Medical Case Reports, 13
  • [44] Remission with Imatinib mesylate treatment in a patient with initially unresectable dermatofibrosarcoma protuberans - A case report
    Lemm D.
    Muegge L.-O.
    Hoeffken K.
    Aklan T.
    Mentzel T.
    Thorwarth M.
    Schultze-Mosgau S.
    Oral and Maxillofacial Surgery, 2008, 12 (4) : 209 - 213
  • [45] Dermatofibrosarcoma protuberans - the use of neoadjuvant imatinib for treatment of an uncommon breast malignancy: a case report
    McGee, Matthew W.
    Boukhar, Sarag A.
    Monga, Varun
    Weigel, Ronald
    Phadke, Sneha D.
    JOURNAL OF MEDICAL CASE REPORTS, 2019, 13 (01)
  • [46] Response of imatinib-resistant extra-abdominal aggressive fibromatosis to sunitinib: case report and review of the literature on response to tyrosine kinase inhibitors
    Skubitz, Keith M.
    Manivel, J. Carlos
    Clohisy, Denis R.
    Frolich, Jerry W.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (03) : 635 - 640
  • [47] Neoadjuvant treatment of Dermatofibrosarcoma Protuberans of pancreas with Imatinib: case report and systematic review of literature
    Dhir, Mashaal
    Crockett, David G.
    Stevens, Todd M.
    Silberstein, Peter T.
    Hunter, William J.
    Foster, Jason M.
    CLINICAL SARCOMA RESEARCH, 2014, 4
  • [48] Response of imatinib-resistant extra-abdominal aggressive fibromatosis to sunitinib: case report and review of the literature on response to tyrosine kinase inhibitors
    Keith M. Skubitz
    J. Carlos Manivel
    Denis R. Clohisy
    Jerry W. Frolich
    Cancer Chemotherapy and Pharmacology, 2009, 64 : 635 - 640
  • [49] Perioperative sunitinib dosing around extensive resections of imatinib-resistant metastatic gastrointestinal stromal tumors
    Raut, C. P.
    Morgan, J. A.
    Quigley, M. T.
    George, S.
    Wagner, A. J.
    Demetri, G. D.
    Bertagnolli, M. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [50] Ripretinib for the treatment of advanced, imatinib-resistant gastrointestinal stromal tumors
    Liu, Wei Zhen
    Du, Yu Qiang
    Shen, Qian
    Tao, Kai Xiong
    Zhang, Peng
    JOURNAL OF DIGESTIVE DISEASES, 2023,
12345